Lantheus Holdings, which sells medical imaging agents used in the diagnosis of cardiovascular diseases, filed on Tuesday with the SEC to raise up to $125 million in an initial public offering. The North Billerica, MA-based company, which was founded in 1956 and booked $286 million in sales for the 12 months ended March 31, 2014, plans to list on the NASDAQ under the symbol LNTH. Lantheus Holdings initially filed confidentially on March 25, 2014. Citi and Jefferies are the joint bookrunners on the deal. No pricing terms were disclosed.
